Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Hypercholesterolemia and NPC1L1[original query] |
---|
An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia. Nutrition, metabolism, and cardiovascular diseases : NMCD 2010 May 20 (4): 236-42. Martín B, Solanas-Barca M, García-Otín A-L, Pampín S, Cofán M, Ros E, Rodríguez-Rey J-C, Pocoví M, Civeira |
Pharmacological treatment of a Sardinian patient affected by Autosomal Recessive Hypercholesterolemia (ARH). Journal of clinical lipidology 0 9 (1): 103-6. Muntoni Sandro, Pisciotta Livia, Muntoni Sergio, Bertolini Stefa |
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2020 3 13 59-70. Calderon-Ospina Carlos Alberto, Hernández-Sómerson Mario, García Ana María, Mejia Adriana, Tamayo-Agudelo Caroll, Laissue Paul, Fonseca Mendoza Dora Jane |
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial. Frontiers in pharmacology 2022 4 13 755469. Liao Jianwei, Yang Liyun, Zhou Luping, Zhao Hongbin, Qi Xiao, Cui Yimin, Ouyang Dongshe |
- Page last reviewed:Feb 1, 2024
- Content source: